Minneapolis, MN (PRWEB) December 12, 2016
RowdMap, Inc. was featured in a recently published article in Merchant Medicine’s ‘The ConvUrgentCare Report’ for its work surrounding the mitigation of low-value care and the evolution of primary care physicians. The article features Joshua Rosenthal, PhD, Chief Scientific Officer of RowdMap, Inc., alongside Anthem, Carolinas Healthcare System, and American Family care. The ConvUrgentCare Report is Merchant Medicine's market report on the walk-in clinic industry. Each month the report includes a feature article covering the on-demand healthcare space. The article is available at: http://bit.ly/2fMtWvr.
Merchant Medicine is a consulting group that focuses on walk-in medicine that offers a competitor database and advanced market assessment. Merchant Medicine is greatly involved in the on-demand community and focuses on collaborating with health systems and large medical groups. The firm is built around four central tenets: Data, Publishing, Community, and Consulting. Merchant Medicine focuses on ConvUrgentCare®, the mingling of operating strategies and tactics from the various submarkets of primary care medicine: preventive medicine, chronic disease management, convenient care (retail clinics), urgent care, work site clinics and telehealth.
The article, entitled “The Changing Face of Primary Care Medicine”, by Tom Charland, CEO of Merchant Medicine, is an overview of the evolution of primary care in a world of ‘consumer-driven care’. Healthcare consumers now expect and want more personalized care in less time. This is where the retail clinics in stores such as Rite-Aid and Walgreens come in with their partnerships with health care systems. In fact, it is estimated that about half of primary care providers will be practicing in an on demand setting in the next ten years. In addition, new economic models are radically changing the way that healthcare is payed for, such as the transition to value-based care. Providers picking up more care at lower intensity, such as PCP’s and retail clinics, stand to substantially benefit from both the new economic models and from routing and controlling care downstream to specialists. “If you are practicing high-value care today and you are in a fee-for-service arrangement, you’re financially upside down,” said Joshua Rosenthal, PhD, Chief Scientific Officer at RowdMap, Inc.
Joshua Rosenthal, PhD, will be elaborating on the themes in the article as a speaker at the upcoming Convurgent Care Strategy Symposium in January of 2017 where he will join Lynn Banaszak Brusco, Executive Director, Disruptive Health Technology Institute, Carnegie Mellon University; Ateev Mehrotra, Harvard Medical School; Valerie Monet, Director of Insurance Practice at J.D. Power and representatives from CVS, Walgreens, Kroger, Rite-Aid.
About RowdMap, Inc:
An Ernst and Young EY Entrepreneur Of The Year® winner, RowdMap’s Risk-Readiness® benchmarks help health plans, physician groups, and hospital systems identify, quantify, and reduce no-value care that physicians deliver- a central tenet of successful pay-for-value programs.
Through practice patterns and referral analysis, RowdMap’s benchmarks identify the health care entities that manage unwarranted and unexpected variation in care. This variation leads to more than $850 Billion in no-value care annually. Payers and physicians use RowdMap’s physician and population health benchmarks to create strategies that put these highest performing physicians at the center of networks and then design products, organize clinical programs, and coordinate sales and marketing around them.
RowdMap’s platform comes preloaded with benchmarks for every physician, hospital, and zip code in the United States- no IT integration required. RowdMap’s Risk-Readiness® Platform works across all market segments and has significantly larger returns than traditional medical economics approaches.
Read the full story at http://www.prweb.com/releases/2016/09/prweb13650039.htm.
Copyright©2016 Vocus, Inc.
All rights reserved